Current developments in salivary diagnostics

Biomarkers in Medicine

Volumn 4, Issue 1, 2010, Pages 171-189

  Miller, Craig S ^a   Foley, Joseph D ^b   Bailey, Alison L ^b   Campell, Charles L ^b,c   Humphries, Roger L ^b   Christodoulides, Nicolaos ^d   Floriano, Pierre N ^d   Simmons, Glennon ^d   Bhagwandin, Bryon ^e   Jacobson, James W ^e   Redding, Spencer W ^f   Ebersole, Jeffrey L ^a   McDevitt, John T ^d  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

^d RICE UNIVERSITY   (United States)

^e LabNow Inc   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute myocardial infarction; Lab on a chip; Periodontitis; Salivary diagnosis

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; AMINOTRANSFERASE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 ANTIGEN; COLLAGEN TYPE 1; CREATINE KINASE MB; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; MYOGLOBIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEINASE INHIBITOR; PROTEOME; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; MICROFLUIDICS; NANOTECHNOLOGY; PERIODONTITIS; PROGNOSIS; REVIEW; SALIVA; SCREENING TEST; VALIDATION STUDY;

BIOLOGICAL MARKERS; BONE REMODELING; CARDIOVASCULAR DISEASES; CONNECTIVE TISSUE; HUMANS; INFLAMMATION MEDIATORS; LAB-ON-A-CHIP DEVICES; PERIODONTAL DISEASES; PROTEOME; SALIVA;

EID: 77951691513     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.68     Document Type: Review

References (148)

1. Mandel ID: The diagnostic uses of saliva. J. Oral Pathol. Med. 19(3), 119-125 (1990).
2. Haeckel R, Hanecke P: The application of saliva, sweat and tear fuid for diagnostic purposes. Ann. Biol. Clin. (Paris) 51(10-11), 903-910 (1993).
3. Kaufman E, Lamster IB: The diagnostic applications of saliva-a review. Crit. Rev. Oral Biol. Med. 13(2), 197-212 (2002).
4. Malamud D: Saliva as a diagnostic fuid. BMJ 305(6847), 207-208 (1992).
5. Malamud D, Niedbala RS (Eds). Oral Based Diagnostics. Annals of the New York Academy of Sciences, Wiley-Blackwell, NY, USA 1098, 1-515 (2007).
6. Wong DT (Ed.). Salivary Diagnostics. John Wiley & Sons, Philadelpha, PA, USA 1-320 (2008).
7. Verkman AS, Yang B, Song Y, Manley GT, Ma T: Role of water channels in fuid transport studied by phenotype ana lysis of aquaporin knockout mice. Exp. Physiol. 85, 233S-241S (2000).
8. Haeckel R, Hanecke P: Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur. J. Clin. Chem. Clin. Biochem. 34(3), 171-191 (1996).
9. Johnson LR: Salivary secretion. In: Gastrointestinal Physiology (6th Edition). Johnson LR (Ed.). Mosby, St. Louis, MO, USA 65-74 (2001).
10. Denny P, Hagen FK, Hardt M et al.: The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J. Proteome. Res. 7(5), 1994-2006 (2008).
11. Hu S, Xie Y, Ramachandran P et al.: Large-scale identifcation of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5(6), 1714-1728 (2005).
12. Helmerhorst EJ, Oppenheim FG: Saliva: a dynamic proteome. J. Dent. Res. 86(8), 680-693 (2007).
13. Mandel ID, Wotman S: The salivary secretions in health and disease. Oral Sci. Rev. 8, 25-47 (1976).
14. Fox PC: Saliva composition and its importance in dental health. Compend. Suppl. 13, S457-S460 (1989).
15. Oberg SG, Izutsu K T, Truelove EL: Human parotid saliva protein composition: dependence on physiological factors. Am. J. Physiol. 242(3), G231-G236 (1982).
16. Rudney JD, Kajander KC, Smith QT: Correlations between human salivary levels of lysozyme, lactoferrin, salivary peroxidase and secretory immunoglobulin A with different stimulatory states and over time. Arch. Oral Biol. 30(11-12), 765-771 (1985).
17. Christodoulides N, Tran M, Floriano PN et al.: A microchip-based multianalyte assay system for the assessment of cardiac risk. Anal. Chem. 74(13), 3030-3036 (2002).
18. Curey TE, Goodey A, Tsao A et al.: Characterization of multicomponent monosaccharide solutions using an enzyme-based sensor array. Anal. Biochem. 293(2), 178-184 (2001).
19. Goodey A, Lavigne JJ, Savoy SM et al:. Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities. J. Am. Chem. Soc. 123(11), 2559-2570 (2001).
20. McCleskey SC, Griffn MJ, Schneider SE, McDevitt JT, Anslyn EV: Differential receptors create patterns diagnostic for ATP and GTP. J. Am. Chem. Soc. 125(5), 1114-1115 (2003).
21. Ali MF, Kirby R, Goodey AP et al.: DNA hybridization and discrimination of single-nucleotide mismatches using chip-based microbead arrays. Anal. Chem. 75(18), 4732-4739 (2003).
22. Christodoulides N, Mohanty S, Miller CS et al.: Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 5(3), 261-269 (2005).
23. Rodriguez WR, Christodoulides N, Floriano PN et al.: A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Med. 2(7), e182 (2005).
24. Christodoulides N, Floriano PN, Acosta SA et al.: Toward the development of a lab-on-a-chip dual-function leukocyte and C-reactive protein ana lysis method for the assessment of infammation and cardiac risk. Clin. Chem. 51(12), 2391-2395 (2005).
25. Floriano PN, Christodoulides N, Romanovicz D et al.: Membrane-based on-line optical ana lysis system for rapid detection of bacteria and spores. Biosens. Bioelectron. 20(10), 2079-2088 (2005).
26. Cohen J: Monitoring treatment: at what cost? Science 304(5679), 1936 (2004)
27. Goodey A P, McDevitt JT: Multishell microspheres with integrated chromatographic and detection layers for use in array sensors. J. Am. Chem. Soc. 125(10), 2870-2871 (2003).
28. McCleskey SC, Floriano PN, Wiskur SL, Anslyn EV, McDevitt JT: Citrate and calcium determination in favored vodkas using artifcial neural networks. Tetrahedron 59(50), 10089-10092 (2003).
29. Wiskur SL, Floriano PN, Anslyn EV, McDevitt JT: A multicomponent sensing ensemble in solution: differentiation between structurally similar analytes. Angew. Chem. Int. Ed. Engl. 42(18), 2070-2072 (2003).
30. Li S, Floriano PN, Christodoulides N et al.: Disposable polydimethylsiloxane/silicon hybrid chips for protein detection. Biosens. Bioelectron. 21(4), 574-580 (2005).
31. Li S, Fozdar D, Ali MF et al.: A continuous fow polymerase chain reaction microchip with regional velocity control. J. Microelectromech. Syst. 14(6), 223-236 (2005).
32. Floriano PN, Christodoulides N, Miller CS et al.: Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin. Chem. 55(8), 1530-1538 (2009).
33. Armitage GC: Diagnosis of periodontal diseases. J. Periodontol. 74(8), 1237-1247 (2003).
34. Petersen PE, Ogawa H: Strengthening the prevention of periodontal disease: the WHO approach. J. Periodontol. 76(12), 2187-2193 (2005).
35. Greenstein G: Current interpretations of periodontal probing evaluations: diagnostic and therapeutic implications. Compend. Contin. Educ. Dent. 26(6), 381-382, 384, 387-390; quiz 398-1389 (2005).
36. Griffths GS: Formation, collection and signifcance of gingival crevice fuid. Periodontol. 2000 31, 32-42 (2003).
37. Fox PC: Salivary monitoring in oral diseases. Ann. NY Acad. Sci. 694, 234-237 (1993).
38. Kaufman E, Lamster IB: Analysis of saliva for periodontal diagnosis-a review. J. Clin. Periodontol. 27(7), 453-465 (2000).
39. Lamster IB, Grbic JT: Diagnosis of periodontal disease based on ana lysis of the host response. Periodontol. 2000 7, 83-99 (1995).
40. Seymour GJ, Gemmell E: Cytokines in periodontal disease: where to from here? Acta Odontol. Scand. 59(3), 167-173 (2001).
41. Lamster IB, Kaufman E, Grbic JT, Winston LJ, Singer RE: b-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J. Periodontol. 74(3), 353-359 (2003).
42. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV: Salivary biomarkers of existing periodontal disease: a cross-sectional study. J. Am. Dent. Assoc. 137(3), 322-329 (2006).
43. Pietruska M, Bernaczyk A, Knas M, Pietruski J, Zwierz K: Assessment of salivary levels of the chosen exoglycosidases in patients with aggressive periodontitis after treatment with doxycycline. Adv. Med. Sci. 51(Suppl. 1), 158-161 (2006).
44. Pederson ED, Stanke SR, Whitener SJ, Sebastiani P T, Lamberts BL, Turner DW: Salivary levels of a2-macroglobulin, a1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch. Oral Biol. 40(12), 1151-1155 (1995).
45. Christodoulides N, Floriano PN, Miller CS et al.: Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann. NY Acad. Sci. 1098, 411-428 (2007).
46. Aurer A, Jorgic-Srdjak K, Plancak D, Stavljenic-Rukavina A, Aurer-Kozelj J: Proinfammatory factors in saliva as possible markers for periodontal disease. Coll. Antropol. 29(2), 435-439 (2005).
47. Kupper TS: Mechanisms of cutaneous infammation. Interactions between epidermal cytokines, adhesion molecules, and leukocytes. Arch. Dermatol. 125(10), 1406-1412 (1989).
48. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by human dermal fbroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 68(1), 31-36 (1989). (Pubitemid 19236065)
49. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ: Gingival fbroblasts degrade type I collagen flms when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. J. Periodont. Res. 24(3), 207-213 (1989).
50. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J. Immunol. 138(5), 1464-1468 (1987).
51. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC: Measurement of interleukin-1 aand-1 b in gingival crevicular fuid: implications for the pathogenesis of periodontal disease. J. Periodontal Res. 25(3), 156-163 (1990).
52. Tsai CC, Ho YP, Chen CC: Levels of interleukin-1 b and interleukin-8 in gingival crevicular fuids in adult periodontitis. J. Periodontol. 66(10), 852-859 (1995).
53. Alexander DC, Martin JC, King PJ, Powell JR, Caves J, Cohen ME: Interleukin-1 b, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fuid in patients undergoing periodontal therapy. J. Periodontol. 67(8), 755-762 (1996).
54. Scannapieco FA, Ng P, Hovey K, Hausmann E, Hutson A, Wactawski-Wende J: Salivary biomarkers associated with alveolar bone loss. Ann. NY Acad. Sci. 1098, 496-497 (2007).
55. Tobon-Arroyave SI, Jaramillo-Gonzalez PE, Isaza-Guzman DM: Correlation between salivary IL-1b levels and periodontal clinical status. Arch. Oral Biol. 53(4), 346-352 (2008).
56. Fine DH, Markowitz K, Furgang D et al.: Macrophage infammatory protein-1a: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J. Periodontol. 80(1), 106-113 (2009).
57. Ng PY, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapieco FA: Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol. Med. Microbiol. 49(2), 252-260 (2007).
58. Nakajima K, Matsuda T, Fujitani Y et al.: Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann. NY Acad. Sci. 762, 55-70 (1995).
59. Janeway CA Jr, Yagi J, Rojo J et al.: Immune recognition and effector function in subsets of CD4 T cells. Princess Takamatsu Symp. 19, 193-208 (1988).
60. Terpos E, Politou M, Viniou N, Rahemtulla A: Signifcance of macrophage infammatory protein-1 a (MIP-1a) in multiple myeloma. Leuk. Lymphoma 46(12), 1699-1707 (2005).
61. Bartold PM, Marshall RI, Haynes DR: Periodontitis and rheumatoid arthritis: a review. J. Periodontol. 76(Suppl. 11), 2066-2074 (2005).
62. Haynes DR: Bone lysis and infammation. Infamm. Res. 53(11), 596-600 (2004).
63. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319(6053), 516-518 (1986).
64. Katagiri T, Takahashi N: Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 8(3), 147-159 (2002).
65. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A: Tumor necrosis factor-a induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275(7), 4858-4864 (2000).
66. Kobayashi K, Takahashi N, Jimi E et al.: Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191(2), 275-286 (2000).
67. Wozniak KL, Arribas A, Leigh JE, Fidel PL Jr: Inhibitory effects of whole and parotid saliva on immunomodulators. Oral Microbiol. Immunol. 17(2), 100-107 (2002).
68. Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS: Bone remodeling biomarkers of periodontal disease in saliva. J. Periodontol. 79(10), 1913-1919 (2008).
69. Grimoud AM, Pontet F, Rousselet F, Lodter JP, Duffaut D, Seguela JP: Comparison of protein concentrations in saliva and serum. Ann. Biol. Clin. (Paris) 46(6), 361-370 (1988).
70. Chu CT, Howard GC, Misra UK et al.: A 2-macroglobulin: a sensor for proteolysis. Ann. NY Acad. Sci. 737, 291-307 (1994).
71. Birkedal-Hansen H, Cobb CM, Taylor RE, Fullmer HM: Serum inhibition of gingival collagenase. J. Oral Pathol. 3(6), 284-290 (1974).
72. Ohlsson M, Rosengren M, Tegner H, Ohlsson K: Quantifcation of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe Seylers Z. Physiol. Chem. 364(9), 1323-1328 (1983).
73. Rao RN, Balamuralikrishnan K, Vasantkumar A, Karanth KS, Bhat MK, Aroor AR: A study of antitrypsin and macroglobulin levels in serum and saliva of patients with gingivitis. Indian J. Dent. Res. 6(2), 41-46 (1995).
74. Aurer A, Aurer-Kozelj J, Stavljenic-Rukavina A, Kalenic S, Ivic-Kardum M, Haban V: Infammatory mediators in saliva of patients with rapidly progressive periodontitis during war stress induced incidence increase. Coll. Antropol. 23(1), 117-124 (1999).
75. Delaisse JM, Engsig MT, Everts V et al.: Proteinases in bone resorption: obvious and less obvious roles. Clin. Chim. Acta 291(2), 223-234 (2000).
76. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5(8), 2145-2154 (1991).
77. Birkedal-Hansen H: Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64, 474-484 (1993).
78. Sodek J, Overall CM: Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl. 1, 352-362 (1992).
79. Tonetti MS, Freiburghaus K, Lang NP, Bickel M: Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J. Periodont. Res. 28, 511-513 (1993).
80. Villela B, Cogen RB, Bartolucci AA, Birkedal-Hansen H: Collagenolytic activity in crevicular fuid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J. Periodontal Res. 22(5), 381-389 (1987).
81. Ingman T, Sorsa T, Suomalainen K et al.: Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fuid in different periodontal diseases. A review article. J. Periodontol. 64(2), 82-88 (1993).
82. Sorsa T, Suomalainen K, Uitto VJ: The role of gingival crevicular fuid and salivary interstitial collagenases in human periodontal diseases. Arch. Oral Biol. 35(Suppl.), 193S-196S (1990).
83. Mäntylä P, Stenman M, Kinane DF et al.: Gingival crevicular fuid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J. Periodontal Res. 38(4), 436-439 (2003)
84. Mäntylä P, Stenman M, Kinane D et al.: Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fuid matrix metalloproteinase-8-specifc chair-side test. J. Periodontal Res. 41(6), 503-512 (2006).
85. Sorsa T, Hernández M, Leppilahti J et al.: Detection of gingival crevicular fuid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. (2009) (Epub ahead of print).
86. Kuula H, Salo T, Pirilä E, Tuomainen AM et al.: Local and systemic responses in matrix metalloproteinase 8-defcient mice during Porphyromonas gingivalis-induced periodontitis. Infect. Immun. 77(2), 850-859 (2009).
87. Bartold PM, Narayanan AS: The biochemistry and physiology of periodontal connective tissues. In: Fundamentals of Periodontics. Wilson TG, Kornman KS (Eds). Quintessence Publishing Co, IL, USA 67-93 (2003).
88. Sorsa T, Tjaderhane L, Konttinen YT et al.: Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal infammation. Ann. Med. 38(5), 306-321 (2006).
89. Gorska R, Nedzi-Gora M: The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch. Immunol. Ther. Exp. (Warsz.) 54(6), 419-426 (2006).
90. Halinen S, Sorsa T, Ding Y et al.: Characterization of matrix metalloproteinase (MMP-8 and-9) activities in the saliva and in gingival crevicular fuid of children with Down's syndrome. J. Periodontol. 67(8), 748-754 (1996).
91. Gangbar S, Overall CM, McCulloch CA, Sodek J: Identifcation of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J. Periodontal Res. 25(5), 257-267 (1990).
92. Ingman T, Sorsa T, Lindy O, Koski H, Konttinen YT: Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fuid of periodontitis patients. J. Clin. Periodontol. 21(1), 26-31 (1994).
93. Makela M, Salo T, Uitto VJ, Larjava H: Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J. Dent. Res. 73(8), 1397-1406 (1994).
94. Herr AE, Hatch AV, Throckmorton DJ et al.: Microfuidic immunoassays as rapid saliva-based clinical diagnostics. Proc. Natl Acad. Sci. USA 104(13), 5268-5273 (2007).
95. Ingman T, Tervahartiala T, Ding Y et al.: Matrix metalloproteinases and their inhibitors in gingival crevicular fuid and saliva of periodontitis patients. J. Clin. Periodontol. 23(12), 1127-1132 (1996).
96. Sorsa T, Ding Y, Salo T et al.: Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann. NY Acad. Sci. 732, 112-131 (1994).
97. Uitto VJ, Suomalainen K, Sorsa T: Salivary collagenase. Origin, characteristics and relationship to periodontal health. J. Periodontal Res. 25(3), 135-142 (1990).
98. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92(8), 827-839 (2003).
99. Shibutani T, Yamashita K, Aoki T, Iwayama Y, Nishikawa T, Hayakawa T: Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J. Bone Miner. Metab. 17(4), 245-251 (1999).
100. Reynolds JJ, Meikle MC: Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol. 2000 14, 144-157 (1997).
101. Rider NL, Craig TJ: Liver enzyme elevation and normal pulmonary function in an adult with a declining forced expiratory volume in 1 second. Allergy Asthma Proc. 29(3), 345-348 (2008).
102. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S: The current state of serum biomarkers of hepatotoxicity. Toxicology 245(3), 194-205 (2008).
103. Sherman KE: Alanine aminotransferase in clinical practice. A review. Arch. Intern. Med. 151(2), 260-265 (1991).
104. Chambers DA, Imrey PB, Cohen RL, Crawford JM, Alves ME, McSwiggin TA: A longitudinal study of aspartate aminotransferase in human gingival crevicular fuid. J. Periodontal Res. 26(2), 65-74 (1991).
105. Hannig C, Spitzmuller B, Hannig M: Transaminases in the acquired pellicle. Arch. Oral Biol. 54(5), 445-448 (2009).
106. Totan A, Greabu M, Totan C, Spinu T: Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin. Chem. Lab. Med. 44(5), 612-615 (2006).
107. Nomura Y, Tamaki Y, Tanaka T et al.: Screening of periodontitis with salivary enzyme tests. J. Oral Sci. 48(4), 177-183 (2006).
108. Welker D: Dental caries susceptibility and transaminases in human saliva. Dtsch Stomatol. 16(12), 910-917 (1966).
109. Musumeci V, Cherubini P, Zuppi C, Zappacosta B, Ghirlanda G, Di Salvo S: Aminotransferases and lactate dehydrogenase in saliva of diabetic patients. J. Oral Pathol. Med. 22(2), 73-76 (1993).
110. Shimada K, Mizuno T, Uchida T, Kato T, Ito K, Murai S: Relationship between levels of aspartate aminotransferase in gingival crevicular fuid and conventional measures of periodontal status assessed using PocketWatch: a cross-sectional study. J. Oral Sci. 41(1), 35-40 (1999).
111. Yucekal-Tuncer B, Uygur C, Firatli E: Gingival crevicular fuid levels of aspartate amino transferase, sulfde ions and N-benzoyl-DL-arginine-2- naphthylamide in diabetic patients with chronic periodontitis. J. Clin. Periodontol. 30(12), 1053-1060 (2003).
112. Shimada K, Mizuno T, Ohshio K, Kamaga M, Murai S, Ito K: Analysis of aspartate aminotransferase in gingival crevicular fuid assessed by using PocketWatch: a longitudinal study with initial therapy. J. Clin. Periodontol. 27(11), 819-823 (2000).
113. Cesco Rde T, Ito IY, de Albuquerque RF Jr: Levels of aspartate aminotransferase (AST) in saliva of patients with different periodontal conditions. J. Clin. Periodontol. 30(8), 752-755 (2003).
114. Zappacosta B, Manni A, Persichilli S et al.: Salivary thiols and enzyme markers of cell damage in periodontal disease. Clin. Biochem. 40(9-10), 661-665 (2007).
115. Yoshie H, Tai H, Kobayashi T et al.: Salivary enzyme levels after scaling and interleukin-1 genotypes in Japanese patients with chronic periodontitis. J. Periodontol. 78(3), 498-503 (2007).
116. Persson GR, DeRouen TA, Page RC: Relationship between gingival crevicular fuid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients. J. Periodontal Res. 25(2), 81-87 (1990).
117. Imrey PB, Crawford JM, Cohen RL, Alves ME, McSwiggin TA, Chambers DA: A cross-sectional ana lysis of aspartate aminotransferase in human gingival crevicular fuid. J. Periodontal Res. 26(2), 75-84 (1991).
118. Ingman T, Sorsa T, Konttinen YT et al.: Salivary collagenase, elastase-and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol. Immunol. 8(5), 298-305 (1993).
119. Uitto VJ, Nieminen A, Coil J, Hurttia H, Larjava H: Oral fuid elastase as an indicator of periodontal health. J. Clin. Periodontol. 23(1), 30-37 (1996).
120. Nieminen A, Nordlund L, Uitto VJ: The effect of treatment on the activity of salivary proteases and glycosidases in adults with advanced periodontitis. J. Periodontol. 64(4), 297-301 (1993).
121. Paster BJ, Russell MK, Alpagot T et al.: Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Ann. Periodontol. 7(1), 8-16 (2002).
122. Kugahara T, Shosenji Y, Ohashi K: Screening for periodontitis in pregnant women with salivary enzymes. J. Obstet. Gynaecol. Res. 34(1), 40-46 (2008).
123. Garnero P, Ferreras M, Karsdal MA et al.: The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J. Bone Miner. Res. 18(5), 859-867 (2003).
124. Garnero P: Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol. Diagn. Ther. 12(3), 157-170 (2008).
125. Delmas PD: Bone marker nomenclature. Bone 28(6), 575-576 (2001).
126. Boyce BF, Xing L: Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 9(Suppl. 1), S1 (2007).
127. Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. J. Am. Med. Assoc. 292(4), 490-495 (2004).
128. Lacey DL, Timms E, Tan HL et al.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2), 165-176 (1998).
129. Buduneli N, Biyikoglu B, Sherrabeh S, Lappin DF: Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J. Clin. Periodontol. 35(10), 846-852 (2008).
130. Callander NS, Roodman GD: Myeloma bone disease. Semin. Hematol. 38(3), 276-285 (2001).
131. Lieben L, Callewaert F, Bouillon R: Bone and metabolism: a complex crosstalk. Horm. Res. 71(Suppl. 1), 134-138 (2009).
132. Brekken RA, Sage EH: SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19(8), 816-827 (2001).
133. Rosamond W, Flegal K, Furie K et al.: Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), e25-e146 (2008)
134. The National Academy of Clinical Biochemistry: Biomarkers of acute coronary syndromes and heart failure. In: Laboratory Medicine Practice Guidelines. Christenson RH (Ed.). The American Association for Clinical Chemistry, Washington, DC, USA, 1-26 (2007).
135. Wilper AP, Woolhandler S, Lasser KE et al.: Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004. Health Aff. (Millwood) 27(2), 84-95 (2008).
136. Ross R: Atherosclerosis-an infammatory disease. N. Engl. J. Med. 340(2), 115-126 (1999).
137. Vasan RS: Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113(19), 2335-2362 (2006).
138. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT: Periodontal disease and risk of cerebrovascular disease: the frst national health and nutrition examination survey and its follow-up study. Arch. Intern. Med. 160(18), 2749-2755 (2000).
139. Baldus S, Heeschen C, Meinertz T et al.: Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108(12), 1440-1445 (2003).
140. Malik I, Danesh J, Whincup P et al.: Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-ana lysis. Lancet 358(9286), 971-976 (2001).
141. Apple FS, Wu AH, Mair J et al.: Future biomarkers for detection of ischemia and risk stratifcation in acute coronary syndrome. Clin. Chem. 51(5), 810-824 (2005).
142. Nakamura M, Slots J: Salivary enzymes. Origin and relationship to periodontal disease. J. Periodontal Res. 18(6), 559-569 (1983).
143. Mellanen L, Lahdevirta J, Tervahartiala T, Meurman JH, Sorsa T: Matrix metalloproteinase-7,-8,-9,-25, and-26 and CD43,-45, and-68 cell-markers in HIV-infected patients' saliva and gingival tissue. J. Oral Pathol. Med. 35(9), 530-539 (2006).
144. Terpos E, Anagnostopoulos A, Kastritis E, Bamias A, Tsionos K, Dimopoulos MA: Abnormal bone remodelling and increased levels of macrophage infammatory protein-1a (MIP-1a) in Waldenstrom macroglobulinaemia. Br. J. Haematol. 133(3), 301-304 (2006).
145. Boyer KG, France JT: Alkaline phosphatase, arylsulfatase and b-glucuronidase in saliva of cyclic women. Int. J. Fertil. 21(1), 43-48 (1976).
146. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F: NF-kB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect. Prev. 29(1), 42-45 (2005).
147. Rhodus NL, Cheng B, Bowles W, Myers S, Miller L, Ondrey F: Proinfammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis. 12(2), 112-116 (2006).
148. Thomas MV, Branscum A, Miller CS, Ebersole J, Al-Sabbagh M, Schuster JL: Within-subject variability in repeated measures of salivary analytes in healthy adults. J. Periodontol. 80(7), 1146-1153 (2009).